Radiopharm Theranostics (ASX:RAD) has announced that the US FDA has granted Rare Pediatric Disease Designation for its DUNP19 technology for the treatment of osteosarcoma.
FDA grants important designation to Radiopharm Theranostics' DUNP19 technology
September 19, 2022 Australian Biotech
Latest Video
New Stories
-
Is this new parliamentary inquiry the latest example of a 'controlling' instinct?
November 23, 2026 - - Latest News -
Former Australian cricketer shares RSV experience as survey reveals gap in personal risk awareness
November 23, 2026 - - Latest News -
Australians unsure of cholesterol levels as campaign challenges heart health myths
November 23, 2026 - -
PBS talks begin under fiscal strains with patients, as always, left outside the room
November 23, 2026 - - Latest News -
While the PBS continues to fall short, we should expect more of these innovative alternatives
November 23, 2026 - - Latest News -
It happened last time, so it makes sense to start next week assuming it as the base case
November 20, 2026 - - Latest News -
Applying the principles of the Reserve Bank review to HTA advisory committees
November 20, 2026 - - Latest News

